ベントラル・メディアル・ヒポタラムス: 低血糖性に関与する
まとめ
視床下部病変はマウスのインスリン抵抗性を高め,を起こすためにインスリン量を2倍にする必要がある. 高用量のインスリンでさえ,血糖値が著しく低下したにもかかわらず,ほとんどの損傷したマウスで発作を引き起こすことができなかった.
科学分野:
- 神経内分泌学の神経内分泌学
- メタボリック研究.
背景:
- 視床下部は,グルコースホメオスタシスとインスリン感受性を調節する.
- 静脈中部下垂体 (VMH) の病変は,肥満や代謝障害を引き起こすことが知られている.
研究 の 目的:
- インスリン誘発のに対するVMH病変の効果を調査する.
- VMH損傷後のインスリン感受性およびグルコース調節の変化を評価する.
主な方法:
- マウスは黄金のチオグルコースを用いてVMHの病変を受けた.
- インスリン耐性試験を実施し,発作に必要な用量を測定しました.
- インスリン投与後の血糖値がモニタリングされた.
主要な成果:
- 損傷を受けたマウスは,対照群と比較して,の発症率の50%を達成するために,インスリン量を2倍にする必要がありました.
- 最大のインスリン投与量 (50mU/g) でさえも,損傷したマウスの60%以上でを起こさなかった.
- 血糖値が ~24 mg/dL に低下したマウスは,広範な発作を引き起こさなかった.
結論:
- VMHの病変は,インスリンがを誘発する能力を著しく低下させる.
- これは,VMH損傷後のグルコース調節および/またはインスリン感受性の実質的な変化を示唆しています.
- VMHは,発作誘導を含むインスリン全身的効果を媒介する上で重要な役割を果たします.
さらに関連する動画
関連する概念動画
Hormones Regulating Blood Glucose
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
Glucose Homeostasis: Regulation of Blood Glucose
Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
Hypoglycemia and Glucagon
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Hypoglycemia
Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
Hyperglycemia
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Diabetic Neuropathy
DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...


